STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc announced the purchase and cancellation of 2,900,000 ordinary shares under the second tranche of its share buyback programme. After settlement, the company’s registered share capital is 8,956,321,411 ordinary shares of £0.01 each, with 3,880,205 held as treasury shares, leaving 8,952,441,206 ordinary shares with voting rights. The company provided a link to a full breakdown of individual trades and noted the announcement does not constitute an offer for securities. The buyback transaction was executed on the London Stock Exchange and details are posted on the company website.

Haleon plc ha comunicato l'acquisto e la cancellazione di 2.900.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario. Dopo l'esecuzione dell'operazione, il capitale sociale registrato della società è pari a 8.956.321.411 azioni ordinarie del valore nominale di £0,01 ciascuna, di cui 3.880.205 sono detenute come azioni proprie, lasciando 8.952.441.206 azioni ordinarie con diritto di voto. La società ha fornito un collegamento con il dettaglio completo delle singole negoziazioni e ha precisato che l'annuncio non costituisce un'offerta di strumenti finanziari. L'operazione di riacquisto è stata eseguita sulla London Stock Exchange e i dettagli sono pubblicati sul sito web della società.

Haleon plc anunció la compra y cancelación de 2.900.000 acciones ordinarias en la segunda tranche de su programa de recompra. Tras la liquidación, el capital social registrado de la compañía asciende a 8.956.321.411 acciones ordinarias de £0,01 cada una, de las cuales 3.880.205 se mantienen como acciones en tesorería, quedando 8.952.441.206 acciones ordinarias con derecho a voto. La compañía facilitó un enlace con el desglose completo de las operaciones individuales y señaló que el anuncio no constituye una oferta de valores. La transacción de recompra se ejecutó en la London Stock Exchange y los detalles están publicados en la página web de la empresa.

Haleon plc는 자사 주식 환매 프로그램 두 번째 트랜치에서 2,900,000 보통주를 매입 및 소각했다고 발표했습니다. 정산 이후 회사의 등록 자본금은 액면가 £0.01인 8,956,321,411 보통주이며, 이 중 3,880,205주는 자사주(금고주)로 보유되어 8,952,441,206 보통주에 의결권이 남아 있습니다. 회사는 개별 거래 내역 전체를 볼 수 있는 링크를 제공했으며, 이번 공고가 증권에 대한 제안을 구성하지는 않는다고 명시했습니다. 환매 거래는 런던 증권거래소에서 실행되었으며 세부 정보는 회사 웹사이트에 게시되어 있습니다.

Haleon plc a annoncé l'achat et la radiation de 2 900 000 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions. Après règlement, le capital social inscrit est de 8 956 321 411 actions ordinaires d'une valeur nominale de £0,01 chacune, dont 3 880 205 sont détenues en tant qu'actions propres, laissant 8 952 441 206 actions ordinaires avec droit de vote. La société a fourni un lien vers la ventilation complète des transactions individuelles et a précisé que l'annonce ne constitue pas une offre de titres. La transaction de rachat a été exécutée à la London Stock Exchange et les détails sont publiés sur le site web de la société.

Haleon plc gab den Kauf und die Löschung von 2.900.000 Stammaktien im Rahmen der zweiten Tranche seines Aktienrückkaufprogramms bekannt. Nach der Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.956.321.411 Stammaktien zu je £0,01, davon werden 3.880.205 als eigene Aktien gehalten, sodass 8.952.441.206 stimmberechtigte Stammaktien verbleiben. Das Unternehmen stellte einen Link mit einer vollständigen Aufschlüsselung der Einzeltransaktionen zur Verfügung und wies darauf hin, dass die Mitteilung kein Angebot von Wertpapieren darstellt. Die Rückkauftransaktion wurde an der London Stock Exchange ausgeführt und die Details sind auf der Unternehmenswebsite veröffentlicht.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Completed tranche of share buyback reduced outstanding voting shares modestly.

The company executed and cancelled 2.9 million shares as part of a previously announced repurchase programme, updating post-settlement share counts. This action reduces the number of ordinary shares with voting rights to 8,952,441,206 and increases treasury share holdings to 3,880,205. The filing supplies a trade-level breakdown link, ensuring transparency on execution. No financial impact figures (cash spent, percentage of market cap or programme size remaining) are disclosed in this notice, limiting assessment of materiality.

TL;DR: Share cancellation is a standard capital management step with governance transparency provided.

The announcement clearly states the cancellation and updated voting share count, which shareholders can use for disclosure threshold calculations under FCA rules. Publication of the full trade breakdown and posting on the investor website aligns with regulatory transparency expectations. The notice does not disclose board rationale, funding source, or remaining programme details, so governance implications are limited to the administrative update provided.

Haleon plc ha comunicato l'acquisto e la cancellazione di 2.900.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto azionario. Dopo l'esecuzione dell'operazione, il capitale sociale registrato della società è pari a 8.956.321.411 azioni ordinarie del valore nominale di £0,01 ciascuna, di cui 3.880.205 sono detenute come azioni proprie, lasciando 8.952.441.206 azioni ordinarie con diritto di voto. La società ha fornito un collegamento con il dettaglio completo delle singole negoziazioni e ha precisato che l'annuncio non costituisce un'offerta di strumenti finanziari. L'operazione di riacquisto è stata eseguita sulla London Stock Exchange e i dettagli sono pubblicati sul sito web della società.

Haleon plc anunció la compra y cancelación de 2.900.000 acciones ordinarias en la segunda tranche de su programa de recompra. Tras la liquidación, el capital social registrado de la compañía asciende a 8.956.321.411 acciones ordinarias de £0,01 cada una, de las cuales 3.880.205 se mantienen como acciones en tesorería, quedando 8.952.441.206 acciones ordinarias con derecho a voto. La compañía facilitó un enlace con el desglose completo de las operaciones individuales y señaló que el anuncio no constituye una oferta de valores. La transacción de recompra se ejecutó en la London Stock Exchange y los detalles están publicados en la página web de la empresa.

Haleon plc는 자사 주식 환매 프로그램 두 번째 트랜치에서 2,900,000 보통주를 매입 및 소각했다고 발표했습니다. 정산 이후 회사의 등록 자본금은 액면가 £0.01인 8,956,321,411 보통주이며, 이 중 3,880,205주는 자사주(금고주)로 보유되어 8,952,441,206 보통주에 의결권이 남아 있습니다. 회사는 개별 거래 내역 전체를 볼 수 있는 링크를 제공했으며, 이번 공고가 증권에 대한 제안을 구성하지는 않는다고 명시했습니다. 환매 거래는 런던 증권거래소에서 실행되었으며 세부 정보는 회사 웹사이트에 게시되어 있습니다.

Haleon plc a annoncé l'achat et la radiation de 2 900 000 actions ordinaires dans le cadre de la deuxième tranche de son programme de rachat d'actions. Après règlement, le capital social inscrit est de 8 956 321 411 actions ordinaires d'une valeur nominale de £0,01 chacune, dont 3 880 205 sont détenues en tant qu'actions propres, laissant 8 952 441 206 actions ordinaires avec droit de vote. La société a fourni un lien vers la ventilation complète des transactions individuelles et a précisé que l'annonce ne constitue pas une offre de titres. La transaction de rachat a été exécutée à la London Stock Exchange et les détails sont publiés sur le site web de la société.

Haleon plc gab den Kauf und die Löschung von 2.900.000 Stammaktien im Rahmen der zweiten Tranche seines Aktienrückkaufprogramms bekannt. Nach der Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.956.321.411 Stammaktien zu je £0,01, davon werden 3.880.205 als eigene Aktien gehalten, sodass 8.952.441.206 stimmberechtigte Stammaktien verbleiben. Das Unternehmen stellte einen Link mit einer vollständigen Aufschlüsselung der Einzeltransaktionen zur Verfügung und wies darauf hin, dass die Mitteilung kein Angebot von Wertpapieren darstellt. Die Rückkauftransaktion wurde an der London Stock Exchange ausgeführt und die Details sind auf der Unternehmenswebsite veröffentlicht.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
03 September 2025- “Transaction in Own Shares”
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
03 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 2,900,000 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
02 September 2025
02 September 2025
02 September 2025
Number of Shares purchased:
2,900,000
-
-
Highest price paid per Share (p):
365.0000
-
-
Lowest price paid per Share (p):
359.5000
-
-
Volume weighted average price paid per Share (p):
363.7313
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,956,321,411 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,952,441,206 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/7269X_1-2025-9-2.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 03, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What shares did Haleon (HLN) repurchase?

Haleon repurchased and cancelled 2,900,000 ordinary shares of £0.01 each under the second tranche of its buyback programme.

How many Haleon shares are outstanding with voting rights after the buyback?

After settlement, there are 8,952,441,206 ordinary shares with voting rights.

How many Haleon shares are held as treasury shares now?

The company holds 3,880,205 treasury shares following the transaction.

Where can I find the detailed trade breakdown for the repurchase?

A full breakdown of individual trades is available at the provided regulatory link and on www.haleon.com/investors.

Does this announcement include the total cash spent on the buyback?

No. The filing does not disclose the aggregate cash amount spent or what percentage of the buyback programme remains.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

44.04B
4.48B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge